A Study of HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLC

Clinical trial NCT04976647 · UNKNOWN

Trial details

NCT number: NCT04976647
Sponsor: Shanghai Henlius Biotech
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Non-small-cell Lung Cancer

Start date: 2022-01-18
Primary completion: 2023-01-30
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.